| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Xcare.net, Inc. |
| 6400 S. Fiddler's Green Circle, Suite 540, Englewood, CO 80111 * (303) 488-2019 |
| Business Description | The company is a leading provider of Internet-based, business-to-business connectivity, information exchange and electronic commerce solutions for healthcare. |
| Offering Information Company has | |||
| Trading As | XCAR (NASNTL) | Industry | Internet (SIC 7374) |
| Type of Stock Offered | Common Shares | Filing Date | 11/2/99 |
| Domestic Shares Offered | 5,000,000 | Offer Date | 2/9/00 |
| Foreign Shares Offered | 0 | Filing Range | $14.00 - $16.00 |
| Company Shares | 5,000,000 | Offer Price | $18.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | - - |
| Gross Proceeds | $90,000,000 | Selling | - - |
| Expenses | - - | Reallowance | - - |
| Post-IPO Shares | 15,300,000 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Robertson, Stephens & Company | Lead Manager | (415) 989-8500 |
| Advest, Inc. | Co-manager | (860) 509-2177 |
| E*OFFERING Corp. | Co-manager | (415) 835-1560 |
| SG Cowen | Co-manager | (212) 495-6000 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 6 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/94 | 12/31/95 | 12/31/96 | 12/31/97 | 12/31/98 | 6/30/98 | 6/30/99 |
| Revenues | 4.310 | 7.708 | 9.726 | 5.984 | 2.270 | 1.042 | 1.841 |
| Income from Oper. | 0.190 | 1.625 | -0.797 | -8.657 | -3.645 | -2.105 | -0.676 |
| Net Income | 0.113 | 1.583 | 0.253 | -7.324 | -4.082 | -2.285 | -0.934 |
| E.P.S | 0.020 | 0.260 | 0.050 | -1.890 | -1.060 | -0.590 | -0.240 |
| Revenue Growth (%) | 78.84 | 26.18 | -38.47 | -62.066 | 76.68 | ||
| Net Income Growth (%) | 1,300.88 | -84.02 | - | - | - | ||
| Oper. Profit Margin (%) | 4.41 | 21.08 | - | - | - | - | - |
| Net Profit Margin (%) | 2.62 | 20.54 | 2.60 | - | - | - | - |
| Cash Flow - Oper. | -2.16 | -2.07 | -0.79 | ||||
| Cash Flow - Inv. | 0.17 | 0.04 | 0.01 | ||||
| Cash Flow - Fin. | 1.49 | 1.57 | 7.11 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 6/30/99 | Financial Ratios | ||||
| Total Assets | 8.27 | Current Assets | 7.08 | Current Ratio | 2.95 |
| Total Liab. | 19.85 | Current Liab. | 2.40 | Debt Ratio | 240.04% |
| Total Equity | -11.58 | Working Cap. | 4.68 | Debt to Equity Ratio | - |
| Cash | 6.52 | Return on Assets | - | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used for general corporate purposes, working capital and capital expenditures for operations, including for research and development, sales and marketing, hardware and software purchases and general and administrative expenses. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Wilson, Sonsini, Goodrich & Rosati |
| Bank's Law Firm | Brobeck, Phleger & Harrison |
| Registrar/Transfer Agent | ChaseMellon Shareholder Services, L.L.C. |
| Auditor | Pricewaterhouse Coopers LLC |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Entities affiliated with Nazem & Company IV, L.P. | 28.00 | |
| Atlantic Medical Capital, L.P. | 23.10 | |
| Vertex Technology Fund (II( Ltd. | 10.80 | |
| Entities affiliated with Sequel Venture Partners II, LLC | 10.80 | |
| CB Healthcare Fund, L.P. | 10.70 | |
| Dauphin Capital Partners I, L.P. | 9.00 | |
| James B. Hoover | 7.80 | |
| Note: represents ownership of 5% or more prior to the offering. | ||